The clinical analysis of 34 intermediate and advanced cardiac cancer with concurrent radiochemotherapy treatment
10.3760/cma.j.issn.1008-6706.2016.17.034
- VernacularTitle:同步放化疗治疗中晚期贲门癌34例临床分析
- Author:
Jinjun WANG
;
Jianjun LI
;
Jingjuan YANG
- Publication Type:Journal Article
- Keywords:
Stomach neoplams;
Radiotherapy,conformal;
Chemotherapy
- From:
Chinese Journal of Primary Medicine and Pharmacy
2016;23(17):2691-2693,2694
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy of concurrent radiochemotherapy in the treatment of intermediate and advanced cardiac cancer.Methods Involved 34 intermediate and advanced cardiac patients,using concurrent radiochemotherapy treatment,the radio treatment with 3D -CRT method,2Gy/time,Qd,5 times per week, total 60Gy/6 week,at the same time,combined with gemcitabine treatment,1 000mg/m2 ,intravenous infusion of 30min.First day and eighth day of medication,forbidding 1 week and used 2 cycles.Results 34 patients all took part in the follow up,the total effective rate was 88.2%,the 1 -,2 -,3 -year survival rate was 70.1%(24 /34),47.0%(16 /34)and 26.5%(9 /34).Adverse reactions were mainly gastrointestinal reaction,bone marrow suppression,etc. Conclusion The concurrent radiochemotherapy treatment can really control the progressive disease,and receive an ideal survival rate,the adverse reactions can limit in tolerance scope.
